Login

Financial Snapshot

Revenue
TTM
$4.984M
Gross Margin
TTM
78.07%
Net Income
TTM
-$341.1K
Current Assets
2024 Q2
Current Liabilities
2024 Q2
Current Ratio
2024 Q2
307.56%
Total Assets
2024 Q2
Total Liabilities
2024 Q2
Book Value
2024 Q2
$2.287M
Cash
2024 Q2
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$125.2K

Stock Price

Loading...
Market Cap: $1.6321 Million

About PROCYON CORP

Procyon Corp. is a holding company, which engages in the development and marketing of proprietary medical products. The company is headquartered in Clearwater, Florida and currently employs 19 full-time employees. AMERX develops and markets medical products used in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation and other skin problems. Its product lines include AMERX, AMERIGEL, HELIX3 Bioactive Collagen, EXTREMIT-EASE Compression Garment and Advantagen Surgical Collagen. AMERX markets a proprietary line of AMERIGEL advanced skin and wound care products made with Oakin, that promote healing in wound and problematic skin conditions, including AMERIGEL Hydrogel Wound Dressing, AMERIGEL Post Op Surgical Kits, AMERIGEL Saline Wound Wash, AMERIGEL Care Lotion, and AMERIGEL Barrier Lotion. HELIX3 is available in Collagen Powder (HELIX3 CP) and Collagen Matrix (HELIX3 CM). Its wound care product includes AMERX Calcium Alginate Dressing, AMERX Foam Dressing, AMERX Gauze Dressing, AMERX Hyrdocolloid Dressing, and AMERX Wound Care Kits.

Industry: Pharmaceutical Preparations Peers: E Med Future, Inc. Arch Therapeutics, Inc. CHEMBIO DIAGNOSTICS, INC. Rapid Therapeutic Science Laboratories, Inc. Vycor Medical Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support